Led by David Altschul, MD, as principal investigator, our neurovascular specialists at Montefiore Einstein are spearheading a clinical trial evaluating the safety and effectiveness of the eShunt System in adult patients with normal pressure hydrocephalus to reduce disability by improving patient comfort, cognitive ability, gait, urinary health and quality of life. This new minimally invasive endovascular technique replaces a surgically created shunt through the venous system of the brain, draining excess cerebrospinal fluid from the subarachnoid space into the venous system, avoiding the surgical risks of an invasive ventriculoperitoneal (VP) shunt procedure. This treatment is performed through a needle stick in the groin, avoiding multiple scalp and abdominal incisions and drilling holes in the skull, which are commonly required for a traditional VP shunt.

In the future, the hope is to expand this technique to patients with other types of hydrocephalus.

If you are interested in enrolling a patient in this clinical trial, please call 718-920-7476.

Clinical Trial: NCT05232838